51st Food and Drug Law Institute Annual Conference Focuses on Relationship Between Scientific Advances and FDA Law & ... ( U.S. Supreme Court Justice Antoni...)

HOME >> MEDICINE >> NEWS

51st Food and Drug Law Institute Annual Conference Focuses on Relationship Between Scientific Advances and FDA Law & Regulation

Date:1/9/2008

U.S. Supreme Court Justice Antonin Scalia, FDA Commissioner Andrew C. von Eschenbach Among Featured Speakers at March 26-27, 2008, FDLI/FDA Meeting in Washington, D.C.

WASHINGTON, Jan. 9 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute's 51st Annual Conference, co-sponsored with the Food and Drug Administration, will focus on the interrelationship between scientific and technological advances and food & drug law & regulation.

FDLI/FDA's March 26-27, 2008 meeting at the L'Enfant Plaza Hotel in Washington, D.C., will include a luncheon speech by U.S. Supreme Court Justice Antonin Scalia and a State of the FDA address by Commissioner Andrew C. von Eschenbach, M.D. Rep. John D. Dingell (D-Mich.) is also an invited featured speaker.

As noted in the recent FDA Science and Mission at Risk Report (http://backweb.fdli.org/pdf/FDAScience.pdf), scientific advances often pose significant policy issues and challenges for legal and regulatory systems. While government agencies are authorized to develop and implement policies that stimulate scientific advances for the benefit of public health, they are also mandated to ensure safety, effectiveness and affordability. The FDLI annual meeting, Scientific Revolution and Legal Evolution: Keeping Pace with Science & Policy Issues in Food and Drug Law, focuses on these dynamic tensions while informing attendees about the impact of recent wide-sweeping food and drug legislation.

Other featured speakers include:

J. Scott Ballenger, Partner, Latham & Watkins;

Brian J. Donato, Partner, Hyman, Phelps & McNamara;

Lillian J. Gill, Director, Office of Compliance, Centers for Devices and Radiological Health, FDA;

Jesse L. Goodman, M.D., Director, Center for Biologics Evaluation and Research, FDA;

Peter Barton Hutt, Partner, Covington & Burling;

Gerald F. Masoudi, Associat
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
2. MCG receives second-time designation from National Cancer Institute
3. Food and Drug Law Institute Sponsors Major Enforcement Conference
4. Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy
5. National Institute on Drug Abuse Director Nora Volkow Speaks about the Dangers of Narcotics on Azteca Americas Political Forum Issues: Caras y Voces
6. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
7. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
8. OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
9. Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
10. The Roskamp Institute Receives Award of Appreciation for Its Continued Innovative and Technological Advances
11. EEG Institute to Provide Free Post-Traumatic Stress Treatment for Iraq and Afghanistan Veterans

Post Your Comments:

51st Food and Drug Law Institute Annual Conference Focuses on Relationship Between Scientific Advances and FDA Law & ...( U.S. Supreme Court Justice Antoni...),Health